UK's Oxford Biomedica tumbles after annual revenue forecast cut
07/08/2026 08:18
UK's Oxford Biomedica tumbles after annual revenue forecast cut Aug 7 (Reuters) - Britain's Oxford Biomedica OXB.L fell more than 22% on Friday after the cell and gene therapy manufacturer cut its 2026 revenue forecast, citing operational delays at a U.S. site and deferred client orders.
(Reporting by Simone Lobo in Bengaluru; Editing by Mrigank Dhaniwala)
((Simone.Lobo@thomsonreuters.com, +919920570373))